|
Getinge, a global medtech company, will strengthen its focus on the Indian market through the company’s India Innovation Centre (IIC) and industry-academia collaborations to cater to global market.
The company has a strong market share in India within several product segments such as ventilators (30%), heart-lung machines (50%), intra-aortic balloon pump (70%), extracorporeal membrane oxygenation (ECMO) (90%), and operating room tables (25%).
Aruna Nayak, managing director, Getinge India, said, “India has made significant advancements in the healthcare sector over the years. During the global Covid-19 pandemic, the company helped healthcare staff saving lives by completing record installations of advanced ventilators, as well as products for (ECMO). Our service engineers were on the forefront and completed around 10,000 service calls related to these products.”
“India is today among the top 10 market for Getinge globally and we are currently working with 10,000 Indian hospitals to create a world class infrastructure. We will continue to be on forefront to not only launch high-end technologies and devices available in India, but also to manufacture in India and make these products available in the US and European Union. We see a lot of investments in the healthcare infrastructure right now and we are well positioned to serve the Indian markets with our high-quality products,” she added.
As part of Getinge’s plans for India, it has set up an Innovation Centre in Bengaluru in January 2020. Through this, it aims to develop advanced and economic solutions for emergency critical care and clinical trials in the country.
Getinge has also tied up with IIT Bombay, the school of biomedical engineering, to develop innovative and economic solutions for emergency critical care based on the critical learnings of the pandemic.
Sunil Joshi, managing director, Innovation Centre at Bengaluru and production and sourcing hub in Mumbai, said, “Partnerships between industry and academia will be instrumental to advancing research in healthcare, fostering innovation, reducing the disease burden on public health systems, and improving clinical outcomes.”
Spending 5% of its annual revenue on R&D, Getinge has R&D units in Sweden, the United States, the UK, Germany, France, China, Netherlands and now India. Getinge believes in a distributive R&D setup to understand local requirements and then subsequently use the best practices to develop a strong presence locally. Such presence is significant to draw expertise from the varied geographies of the medtech sector. Getinge will continue to invest in ecosystems that will develop around innovation hubs. Its Innovation Centre facility at Bengaluru is equipped with high-speed computing to simulate real-life challenges with software and medical equipment.
“Our Innovation Centre is equipped to create automated programs that can undertake rigorous and complex testing for medical equipment with minimum human intervention," he said.
Sergio Silva, director, global projects, production & sourcing hub, Getinge, said; “India has always been an important market for us. In 2020, we decided to set up local manufacturing for our modular walls solutions, called Getinge IN2. This has proven to be very successful, both locally for the Indian market, but also export-wise to the Middle East, South East Asia and Europe since a couple of years back. Last year, more than 40% of our IN2 business came from our India manufacturing hub. We are now further expanding our manufacturing portfolio with Getinge IN2 to support more hospitals in India.”
|